URB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.661400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.614800E-01
Normal-vs-Stage2
8.293200E-01
Normal-vs-Stage3
7.062600E-01
Normal-vs-Stage4
6.314800E-01
Stage1-vs-Stage2
7.441400E-01
Stage1-vs-Stage3
2.667800E-01
Stage1-vs-Stage4
9.161800E-01
Stage2-vs-Stage3
4.725800E-01
Stage2-vs-Stage4
8.428600E-01
Stage3-vs-Stage4
3.459400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.509600E-01
Normal-vs-AfricanAmerican
3.980000E-01
Normal-vs-Asian
6.423600E-01
Caucasian-vs-AfricanAmerican
3.453400E-01
Caucasian-vs-Asian
2.609800E-01
AfricanAmerican-vs-Asian
8.048100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.294600E-01
Normal-vs-Female
9.128400E-01
Male-vs-Female
6.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.569600E-01
Normal-vs-Age(41-60Yrs)
6.001800E-01
Normal-vs-Age(61-80Yrs)
9.834000E-01
Normal-vs-Age(81-100Yrs)
8.909200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.818600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.856000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.208800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.111570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.944400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.464000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.981200E-01
Normal-vs-Daily Drinker
6.942200E-01
Normal-vs-Weekly Drinker
7.089200E-01
Normal-vs-Occasional Drinker
8.579000E-01
Normal-vs-Social Drinker
4.148000E-01
Non Drinker-vs-Daily Drinker
4.165000E-01
Non Drinker-vs-Weekly Drinker
3.912600E-01
Non Drinker-vs-Occasional Drinker
7.726800E-01
Non Drinker-vs-Social Drinker
1.335960E-01
Daily Drinker-vs-Weekly Drinker
1.654430E-01
Daily Drinker-vs-Occasional Drinker
2.497400E-01
Daily Drinker-vs-Social Drinker
2.896100E-02
Weekly Drinker-vs-Occasional Drinker
5.302600E-01
Weekly Drinker-vs-Social Drinker
7.336600E-01
Occasional Drinker-vs-Social Drinker
1.288560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.268200E-01
Normal-vs-Grade 2
1.540020E-01
Normal-vs-Grade 3
5.758300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.075760E-01
Grade 1-vs-Grade 3
6.072300E-02
Grade 1-vs-Grade 4
2.268200E-01
Grade 2-vs-Grade 3
9.541000E-01
Grade 2-vs-Grade 4
1.540020E-01
Grade 3-vs-Grade 4
5.758300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.704400E-01
Normal-vs-NonDiabetic
9.434600E-01
Diabetic-vs-NonDiabetic
4.874800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.106000E-01
Normal-vs-NoPancreatitis
9.895200E-01
Pancreatitis-vs-NoPancreatitis
1.949170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.559400E-01
Normal-vs-N1
8.433800E-01
N0-vs-N1
5.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.161400E-01
Normal-vs-TP53-NonMutant
7.831200E-01
TP53-Mutant-vs-TP53-NonMutant
6.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
